Agree. Here is another great Frontiers article fr

Agree. Here is another great Frontiers article from 4 years ago. It touches on the CCR5 pathology, a few of the indications ohm has on his list and mentions leronlimab and other CCR5 antagonists. Definitely recommend for those who haven't read it previously or need a little positive scientific info for their weekend.

https://www.frontiersin.org/articles/10.3389/...01981/full

Please do your own due diligence. All my posts and comments are not to be considered investment advice.